XML 50 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Payments - 2017 Share Incentive Plan (Details) - 2017 Share Incentive Plan
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 26, 2017
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2018
item
Options            
Outstanding at beginning of year (in shares)       4,422,664    
Granted (in shares)       1,290,500    
Forfeited (in shares)       (748,874)    
Outstanding at end of year (in shares)   4,964,290   4,964,290    
Vested and exercisable at end of year (in shares)   1,968,950   1,968,950    
Weighted average exercise price in $ per share            
Outstanding balance at beginning of year (in dollars per share) | $ / shares       $ 3.55    
Granted (in dollars per share) | $ / shares       1.35    
Forfeited (in dollars per share) | $ / shares       2.56    
Outstanding balance at end of year (in dollars per share) | $ / shares   $ 3.13   3.13    
Vested and exercisable balance at end of year (in dollars per share) | $ / shares   $ 4.21   $ 4.21    
Fair Value Assumptions            
Weighted-average remaining contractual life       8 years 8 months 12 days    
Stock Options            
Share-Based Payments            
Vesting period       10 years    
Fair Value Assumptions            
Expected term of options (in years)   6 years 1 month 6 days        
Stock-Based Compensation Expense            
Share-based compensation expense | $   $ 0.5 $ 0.8 $ 1.1 $ 1.3  
Weighted-average grant date fair value (in dollars per share) | $ / shares       $ 0.80    
Unrecognized compensation expense            
Total unrecognized compensation related to unvested options | $   3.9   $ 3.9    
Recognition period       1 year 1 month 6 days    
Stock Options | Minimum            
Fair Value Assumptions            
Expected volatility (as a percent)       63.80%    
Risk-free interest rate (as a percent)       0.80%    
Term of U.S. treasury securities used to estimate risk free interest rate       5 years    
Stock Options | Maximum            
Fair Value Assumptions            
Expected volatility (as a percent)       64.00%    
Risk-free interest rate (as a percent)       1.50%    
Term of U.S. treasury securities used to estimate risk free interest rate       7 years    
SARs            
Share-Based Payments            
Vesting period       10 years    
Restricted Stock Units ("RSUs")            
Share-Based Payments            
Vesting period       4 years    
Fair Value | $       $ 0.4    
Stock-Based Compensation Expense            
Share-based compensation expense | $   0.4 $ 0.4 1.0 $ 0.6  
Unrecognized compensation expense            
Total unrecognized compensation related to unvested options | $   $ 2.6   $ 2.6    
Recognition period       1 year 3 months 18 days    
Restricted Stock Units            
Weighted average grant date fair value per share | $ / shares       $ 1.35    
Number of shares outstanding       901,686    
Granted       1,557,300    
Vested and issued       (334,210)    
Forfeited       (230,792)    
Number of shares outstanding   1,893,984   1,893,984    
weighted average fair value per share            
Weighted average fair value at the beginning | $ / shares       $ 3.69    
Granted | $ / shares       1.35    
Vested and issued | $ / shares       2.03    
Forfeited | $ / shares       1.83    
Weighted average fair value at the end | $ / shares   $ 1.83   $ 1.83    
Restricted Stock Units ("RSUs") | Vesting period, year one            
Restricted Stock Units            
Percentage that vests during the period       25.00%    
Restricted Stock Units ("RSUs") | Employees            
Share-Based Payments            
Number of vesting periods | item           3
Vesting period       4 years   6 months
Restricted Stock Units            
Percentage that vests during the period       25.00%    
Ordinary Shares            
Share-Based Payments            
Number of shares authorized 3,000,000          
Additional shares authorized 3,438,990          
Shares available for grant   1,829,811   1,829,811    
Ordinary Shares | Minimum            
Share-Based Payments            
Annual increase, to be added on the first day of each fiscal year (in shares) 2,000,000          
Annual increase, to be added on the first day of each fiscal year (as a percent) 4.00%          
XENLETA | Restricted Stock Units ("RSUs") | Immediate vesting upon regulatory approval            
Restricted Stock Units            
Percentage that vests during the period           50.00%
XENLETA | Restricted Stock Units ("RSUs") | Vesting upon the one-year-anniversary of FDA approval            
Restricted Stock Units            
Percentage that vests during the period           50.00%
CONTEPO | Restricted Stock Units ("RSUs") | Immediate vesting upon regulatory approval            
Restricted Stock Units            
Percentage that vests during the period           50.00%
CONTEPO | Restricted Stock Units ("RSUs") | Vesting upon the one-year-anniversary of FDA approval            
Restricted Stock Units            
Percentage that vests during the period           50.00%